We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$13.7B
Cap. Flow %
-12.39%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Miscellaneous 38.33%
2 Technology 14.87%
3 Consumer Discretionary 9.92%
4 Healthcare 7.34%
5 Financials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDS.A
2901
PUT
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.96M ﹤0.01%
43,900
-43,800
-50% -$1.77M
BURU
2902
DELISTED
NUBURU INC
BURU
$1.96M ﹤0.01%
+1,002
New +$1.95M
EMR icon
2903
Emerson Electric
EMR
$88B
$1.95M ﹤0.01%
20,718
-4,210
-17% -$420K
NOK icon
2904
CALL
Nokia
NOK
$59.3B
$1.95M ﹤0.01%
357,900
SCHL icon
2905
Scholastic
SCHL
$738M
$1.95M ﹤0.01%
54,740
-800
-1% -$27.3K
ESLA icon
2906
Estrella Immunopharma
ESLA
$31.4M
$1.95M ﹤0.01%
+197,000
New +$1.94M
ACCD
2907
CALL
DELISTED
Accolade Inc
ACCD
$1.95M ﹤0.01%
46,200
ZTS icon
2908
PUT
Zoetis
ZTS
$31B
$1.94M ﹤0.01%
10,000
AMG icon
2909
CALL
Affiliated Managers Group
AMG
$9.58B
$1.93M ﹤0.01%
+12,800
New +$2.1M
CME icon
2910
CALL
CME Group
CME
$101B
$1.93M ﹤0.01%
10,000
-20,000
-67% -$4.05M
RVLV icon
2911
PUT
Revolve Group
RVLV
$1.63B
$1.93M ﹤0.01%
+31,300
New +$2.04M
QUAD icon
2912
Quad
QUAD
$518M
$1.93M ﹤0.01%
454,649
-80,232
-15% -$331K
ITQ
2913
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$1.93M ﹤0.01%
+198,006
New +$1.91M
NDAQ icon
2914
CALL
Nasdaq
NDAQ
$55.5B
$1.93M ﹤0.01%
+30,000
New +$1.89M
BHR
2915
Braemar Hotels & Resorts
BHR
$142M
$1.93M ﹤0.01%
397,799
-201,597
-34% -$1.05M
SGFY
2916
DELISTED
Signify Health, Inc.
SGFY
$1.93M ﹤0.01%
+107,743
New +$2.77M
RDWR icon
2917
Radware
RDWR
$1.24B
$1.92M ﹤0.01%
57,063
-12,128
-18% -$401K
HLAH
2918
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
$1.92M ﹤0.01%
198,368
+50,574
+34% +$491K
MCAE
2919
DELISTED
Mountain Crest Acquisition Corp. III Common Stock
MCAE
$1.92M ﹤0.01%
+195,347
New +$1.9M
PLAY icon
2920
CALL
Dave & Buster's
PLAY
$319M
$1.92M ﹤0.01%
50,000
MP icon
2921
MP Materials
MP
$10.5B
$1.92M ﹤0.01%
59,460
+42,576
+252% +$1.48M
BZUN
2922
CALL
Baozun
BZUN
$176M
$1.91M ﹤0.01%
109,200
+66,400
+155% +$1.63M
KB icon
2923
KB Financial Group
KB
$42.6B
$1.91M ﹤0.01%
41,190
-62,243
-60% -$2.81M
EXAS
2924
CALL
DELISTED
Exact Sciences
EXAS
$1.91M ﹤0.01%
20,000
+10,000
+100% +$1.06M
FL
2925
DELISTED
Foot Locker
FL
$1.91M ﹤0.01%
+41,808
New +$2.32M

Similar funds

David Shaw's Q3 2021 Portfolio in Review

As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

David Shaw withdrew a net $13.7B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, David Shaw opened a new position in Sea Limited worth $206M.

  • David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • David Shaw opened 915 new positions and closed 695 in Q3 2021.
  • David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.